|
US5744500A
(en)
*
|
1990-01-03 |
1998-04-28 |
Teva Pharmaceutical Industries, Ltd. |
Use of R-enantiomer of N-propargyl-1-aminoindan, salts, and compositions thereof
|
|
IL118836A
(en)
|
1996-07-11 |
2001-01-11 |
Teva Pharma |
Pharmaceutical compositions comprising s-(-)-n-propargyl-1-aminoindan
|
|
AU2002244247B2
(en)
|
2001-03-01 |
2007-12-13 |
Harbor Biosciences, Inc. |
Use of certain steroids for treatment of blood cell deficiencies
|
|
US20040138187A1
(en)
|
2002-08-28 |
2004-07-15 |
Reading Christopher L. |
Therapeutic treatment methods
|
|
JP4757024B2
(ja)
*
|
2002-11-07 |
2011-08-24 |
テクニオン リサーチ アンド ディベラップメント ファウンデイション リミテッド |
神経保護鉄キレート剤及びそれを含む医薬組成物
|
|
DK1567152T3
(da)
|
2002-11-15 |
2013-10-07 |
Teva Pharma |
Anvendelse af rasagilin med riluzol til behandling af amyotroph lateral sklerose
|
|
US8097608B2
(en)
*
|
2003-11-25 |
2012-01-17 |
Technion Research And Development Foundation Ltd. |
Methods for treatment of cardiovascular disorders and diseases
|
|
EP1686973A4
(en)
|
2003-11-25 |
2009-03-25 |
Technion Res & Dev Foundation |
COMPOSITIONS AND METHODS FOR THE TREATMENT OF CARDIOVASCULAR DISEASES AND DISEASES
|
|
JP2005232148A
(ja)
*
|
2004-02-03 |
2005-09-02 |
Technion Research & Development Foundation Ltd |
神経保護剤としてプロパルギルアミンの使用
|
|
AU2005269416B2
(en)
*
|
2004-07-26 |
2011-07-28 |
Teva Pharmaceutical Industries, Ltd. |
Pharmaceutical dosage forms including rasagiline
|
|
US20060025446A1
(en)
*
|
2004-07-27 |
2006-02-02 |
Jeffrey Sterling |
Propargyl nitroxides and indanyl nitroxides and their use for the treatment of neurologic diseases and disorders
|
|
WO2006110172A2
(en)
|
2004-09-29 |
2006-10-19 |
Hollis-Eden Pharmaceuticals.Inc. |
Steroid analogs and characterization and treatment methods
|
|
PT1848415E
(pt)
*
|
2005-02-17 |
2013-06-27 |
Teva Pharma |
Terapia de combinação com acetato de glatirâmero e rasagilina para o tratamento da esclerose múltipla
|
|
JP5738509B2
(ja)
|
2005-02-23 |
2015-06-24 |
テバ ファーマシューティカル インダストリーズ リミティド |
内容物均一性が改善されたラサギリン製剤
|
|
US8263655B2
(en)
|
2005-10-06 |
2012-09-11 |
Technion Research And Development Foundation Ltd |
Methods for treatment of renal failure
|
|
CN101622225B
(zh)
*
|
2005-11-17 |
2015-04-15 |
泰华制药工业有限公司 |
炔丙基氨基茚分离方法
|
|
US7572834B1
(en)
|
2005-12-06 |
2009-08-11 |
Teva Pharmaceutical Industries, Ltd. |
Rasagiline formulations and processes for their preparation
|
|
EP1956904B1
(en)
|
2005-12-09 |
2017-04-12 |
Yissum Research Development Company of the Hebrew University of Jerusalem Ltd. |
Low-dose ladostigil for the treatment of mild cognitive impairment
|
|
JP5701485B2
(ja)
|
2006-02-21 |
2015-04-15 |
テバ ファーマシューティカル インダストリーズ リミティド |
多系統萎縮症の治療のためのラサギリンの使用
|
|
TW200744576A
(en)
|
2006-02-24 |
2007-12-16 |
Teva Pharma |
Propargylated aminoindans, processes for preparation, and uses thereof
|
|
WO2007117431A2
(en)
|
2006-04-03 |
2007-10-18 |
Teva Pharmaceutical Industries, Ltd. |
Use of rasagiline for the treatment of restless legs syndrome
|
|
EP1892233A1
(de)
*
|
2006-08-18 |
2008-02-27 |
Ratiopharm GmbH |
Neue Salze des Wirkstoffs Rasagilin
|
|
NZ577623A
(en)
*
|
2006-12-14 |
2011-05-27 |
Teva Pharma |
Tannate salt of rasagiline
|
|
CN101557706B
(zh)
*
|
2006-12-14 |
2013-08-07 |
泰华制药工业有限公司 |
雷沙吉兰碱结晶固体
|
|
EP1987816A1
(de)
*
|
2007-04-30 |
2008-11-05 |
Ratiopharm GmbH |
Adsorbate eines Rasagilinsalzes mit einem wasserlöslichen Hilfsstoff
|
|
JP2010538067A
(ja)
*
|
2007-09-05 |
2010-12-09 |
テバ ファーマシューティカル インダストリーズ リミティド |
ラサギリンを使用する緑内障の治療方法
|
|
US8188149B2
(en)
*
|
2007-09-17 |
2012-05-29 |
Teva Pharmaceutical Industries, Ltd. |
Use of R(+)-N-propargy1-1-aminoindan to treat or prevent hearing loss
|
|
MX2010007601A
(es)
*
|
2008-01-11 |
2010-08-03 |
Teva Pharma |
Formulaciones de rasagilina, su preparacion y uso.
|
|
WO2009122351A2
(en)
*
|
2008-04-01 |
2009-10-08 |
Kangwon National University |
Anti-parkinsonian compounds mppe
|
|
JP2011524353A
(ja)
*
|
2008-06-10 |
2011-09-01 |
テバ ファーマシューティカル インダストリーズ リミティド |
ラサギリン軟ゼラチンカプセル
|
|
EA201170018A1
(ru)
*
|
2008-06-13 |
2011-08-30 |
Тева Фармасьютикал Индастриз, Лтд. |
Разагилин для изменения течения болезни паркинсона
|
|
CN102065853A
(zh)
*
|
2008-06-19 |
2011-05-18 |
泰华制药工业有限公司 |
制备和干燥固体雷沙吉兰碱的方法
|
|
EP2299993A4
(en)
*
|
2008-06-19 |
2014-08-20 |
Teva Pharma |
PROCESS FOR PURIFYING THE BASE OF RASAGILINE
|
|
US8080584B2
(en)
*
|
2009-01-23 |
2011-12-20 |
Teva Pharmaceuticals Industries, Ltd. |
Delayed release rasagiline citrate formulation
|
|
CA2767592A1
(en)
|
2009-07-09 |
2011-01-13 |
Ratiopharm Gmbh |
Salts of rasagiline and pharmaceutical preparations thereof
|
|
EP2531181B1
(en)
|
2010-02-03 |
2019-04-10 |
Pharma Two B Ltd. |
Extended release formulations of rasagiline and uses thereof
|
|
RU2013108256A
(ru)
|
2010-07-27 |
2014-09-10 |
Тева Фармасьютикал Индастриз Лтд. |
Дисперсии цитрата разагилина
|
|
AU2011282720B2
(en)
|
2010-07-27 |
2016-12-22 |
Teva Pharmaceutical Industries Ltd. |
Use of rasagiline for the treatment of olfactory dysfunction
|
|
HK1200315A1
(en)
|
2011-10-10 |
2015-08-07 |
Teva Pharmaceutical Industries Ltd. |
R(+)-n-formyl-propargyl-aminoindan
|
|
AU2012323351A1
(en)
|
2011-10-10 |
2014-05-22 |
Teva Pharmaceutical Industries Ltd. |
R(+)-N-methyl-propargyl-aminoindan
|
|
JP2015529196A
(ja)
|
2012-08-17 |
2015-10-05 |
テバ ファーマシューティカル インダストリーズ リミティド |
ラサギリンの非経口製剤
|
|
CN104177611A
(zh)
*
|
2013-05-27 |
2014-12-03 |
韩文毅 |
一种非线性的聚合物及其制备和用途
|
|
CN104177610A
(zh)
*
|
2013-05-27 |
2014-12-03 |
韩文毅 |
一种非线性的聚合物及其制备和用途
|
|
CN111333517A
(zh)
*
|
2018-12-19 |
2020-06-26 |
上海奥博生物医药技术有限公司 |
一种制备雷沙吉兰的改进方法
|